APPW2025

^○Momoka Okada, Shuma Naazawa, Hitomi Takahashi, Koki Hayashi, Natusmi Yamaguchi, Jin Nakatani, Toshinori Sawano, Hidekazu Tanaka (Ritsumeikan University Graduate School of Life Sciences Pharmacology Laboratory)

^○Ryosuke Yoshida¹, Yuji Ikegaya^1,2, Ryuta Koyama^1,3 (1.The University of Tokyo, 2.The Institute for AI and Beyond, The University of Tokyo, 3.National Center of Neurology and Psychiatry)

^○Shoichiro Omura^1,2, Hiroki Ikeda¹, Rina Ogawa¹, Tomomi Kawachi¹, Aya Ogawa¹, Yuuki Arai¹, Natsumi Takayama¹, Aki Masui¹, Kumiko Kondo¹, Hiroki Sugimoto¹, Hiroshi Shinohara¹, Tokiharu Takahashi¹, Hideyuki Maeda³, Kyoji Ohyama¹ (1.Tokyo Medical University Department of Histology and Neuroanatomy, 2.Tokyo Medical University Department of Psychiatry, 3.Osaka University Department of Legal Medicine)

^○Naoki Mukai¹, Mohammed E Choudhury², Ayane Takenaga³, Kouichi Tanaka⁴, Norio Sato¹, Junya Tanaka² (1.Ehime Univ. Department of Emergency and Critical Care Medicine, 2.Ehime Univ. Department of Molecular and Cellular Physiology, 3.Ehime Univ. School of Medicine, 4.Ehime Prefectural Central Hospital. Advanced Emergency and Critical Care Center)

^○Nozomi Tokunaga, Yoki Nakamura, Kazue Hisaoka-Nakashima, Norimitsu Morioka (Department of Pharmacology, Graduate School of Biomedical & Health Sciences, Hiroshima University)

^○Yusuke Takahashi, Ikoma Yoko, Matsui ko (Super-network Brain Physiology, Graduate School of Life Sciences, Tohoku University)

^○Hitomi Takahashi, Shuma Nakazawa, Momoka Okada, Yosuke Inoue, Shota Inoue, Natsumi Yamaguchi, Jin Nakatani, Toshinori Sawano, Hidekazu Tanaka (Ritsumeikan Univ., Dept. Life Sci., Lab. Pharmacol.)

^○Akari Hashimoto^1,10, Nanami Kawamura², Etsuko Tarusawa², Ikuko Takeda^1,10, Yuki Aoyama¹, Nobuhiko Ohno^3,4, Mio Inoue¹, Mai Kagamiuchi¹, Daisuke Kato¹, Mami Matsumoto^5,6, Yoshihiro Hasegawa¹, Junichi Nabekura⁷, Anne Schaefer^8,9, Takeshi Yagi², Hiroaki Wake^{1,10,11,12,13} (1.Department of Anatomy and Molecular Cell Biology, Nagoya University Graduate School of Medicine, 2.KOKORO-Biology Group, Laboratories for Integrated Biology, Graduate School of Frontier Biosciences, Osaka University, 3.Department of Anatomy, Division of Histology and Cell Biology, Jichi Medical University, 4.Division of Ultrastructural Research, National Institute for Physiological Sciences, 5.Section of Electron Microscopy, Supportive Center for Brain Research, National Institute for Physiological Sciences, 6.Department of Developmental and Regenerative Neurobiology, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, 7.Division of Homeostatic Development, National Institute for Physiological Sciences, 8.Center for Glial Biology, Department of Neuroscience and Psychiatry, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 9.Max Planck Institute for Biology of Ageing, 10.Division of Multicellular Circuit Dynamics, National Institute for Physiological Sciences, 11.Center for Optical Scattering Image Science, Kobe University, 12.Department of Physiological Sciences, Graduate University for Advanced Studies, SOKENDAI, 13.Core Research for Evolutional Science and Technology, Japan Science and Technology Agency)

^○Kana Yamamoto, Hanahusa Hiroaki, Nomura Jun, Takumi Toru (Kobe University School of Medicine Department of Physiology)

^○Yuki Nagai^1,2, Eiji Shigetomi^1,2, Toru Tateoka^3,2, Yuka Fujimoto^1,2, Miho Miyakawa^1,2, Hideyuki Yoshioka^3,2, Hiroyuki Kinouchi^3,2, Schuichi Koizumi^1,2 (1.Dept Neuropharmacol, Interdiscipl Grad Sch Med, Univ Yamanashi, 2.Yamanashi GLIA center, Univ Yamanashi, 3.Dept Neurosurgery, Interdiscipl Grad Sch Med, Univ Yamanashi)

^○Kohei Nomaki¹, Risako Fujikawa², Takahiro Masuda³, Takaomi Saido⁴, Takashi Saito⁵, Makoto Tsuda¹ (1.Dept. Mol. and Syst Pharmacol., Grad. Sch. Pharma. Sci., Kyushu Univ., 2.Dept. Neuropharmacology, Fac. Pharma. Sci., Fukuoka Univ., 3.Div. Mol. Neuroimmunology, Med. Inst. Bioregulation, Kyushu Univ., 4.Lab. Proteolytic Neuroscience, RIKEN Ctr. Brain Sci., 5.Dept. Neurocognitive Sci., Inst. Brain Sci., Grad. Sch. Med. Sci., Nagoya City Univ.)

^○Kazuma Miyata¹, Yuji Ikegaya¹, Ryuta Koyama^2,1 (1.Graduate School of Pharmaceutical Sciences, The University of Tokyo, 2.Department of Translational Neurobiology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

^○Rina Mimoto¹, Naoya Fukuda¹, Kouki Toriuchi¹, Hiromasa Aoki¹, Hiroki Kakita^2,1, Yoshiaki Suzuki¹, Satoru Takeshita^2,1, Tetsuya Tamura³, Hisao Yamamura¹, Yasumichi Inoue¹, Hidetoshi Hayashi¹, Yasumasa Yamada², Mineyoshi Aoyama¹ (1.Nagoya City University Graduate School of Pharmaceutical Science, 2.Department of Perinatal and Neonatal Medicine, Aichi Medical University, 3.Nagoya City University Graduate School of Medical Sciences)

^○Hiroki Hoshino^1,2,3, Fumikazu Sano^1,2,4, Eiji Shigetomi^1,2, Hideyuki Takeuchi^5,6,7, Hideaki Kanemura³, Schuichi Koizumi^1,2 (1.Department of Neuropharmacology, Interdisciplinary of Graduate School of Medicine, University of Yamanashi, 2.Yamanashi GLIA center, 3.Department of Pediatrics, Faculty of Medicine, University of Toho, 4.Department of Pediatrics, Faculty of Medicine, University of Yamanashi, 5.Department of Neurology, Yokohama City University Graduate School of Medicine, 6.Department of Neurology, Faculty of Medicine, International University of Health and Walfare, 7.Center of intractable neurological disease and dementia, International University of Health and Walfare Atami Hospital)

^○Ken Ueda¹, Kazuki Harada¹, Yuri Osuga¹, Hiromu Monai², Takashi Tsuboi¹ (1.Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 2.Department of Biology, Faculty of Science, Ochanomizu University)